Previous studies demonstrated significant structural, functional, and metabolic abnormalities in AD cerebella [57-59,82], including insulin and IGF resistance [30], similar to the findings in more traditional targets of AD, i.e. cortical and limbic structures. The gene discussed is INS; the disease is Alzheimer disease.